Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSkin reactions are among the most commonly reported side effects of tirzepatide. Most are mild, local, and settle within a few days of each injection. A small number of people experience something more significant, and knowing how to tell the difference matters. These are prescription-only medicines, reviewed by a clinician before you start, and your prescriber is the right person to contact if anything concerns you. This page walks through what the research and clinical guidance say, step by step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most frequently reported skin reactions with tirzepatide happen right where the pen meets your skin. You might notice a small red patch, a tender spot, or mild swelling around the injection site in the hours after your weekly dose. Some people describe a faint itching or a slightly raised bump that lingers for a day or two.
These are documented in the tirzepatide SmPC and reflected in NHS guidance on tirzepatide. They are more likely to appear in the first few weeks of treatment, particularly around dose increases, when your body is still adjusting. Most resolve without any treatment at all.
A cool, clean cloth held gently against the site for a few minutes can ease discomfort. Over-the-counter antihistamine cream may help with itching, but check with a pharmacist or your prescriber before applying anything to broken or irritated skin. What you should not do is rub the injection site vigorously or apply heat.
Worth noting: if you want a closer look at how a site reaction to tirzepatide typically presents and what distinguishes it from something more concerning, our dedicated page walks through the details. Taking your pen out and letting it sit at room temperature for around 30 minutes before injecting is widely recommended, though you should confirm the exact warming window with your patient information leaflet rather than guessing.
One of the simplest, most effective things you can do is vary where you inject each week. Tirzepatide can be administered in the abdomen, the outer thigh, or the upper arm. Returning to exactly the same spot repeatedly can cause a small area of hardened or thickened tissue called lipohypertrophy, which not only looks and feels uncomfortable but can also affect how consistently your medicine is absorbed.
A practical approach is to think of each injection zone as a clock face: move around it methodically so no single point is used more than once every few weeks. If you inject into your abdomen, avoid the two inches directly around your navel. Our broader guide to Mounjaro side effects covers this alongside other common reactions you might encounter during treatment.
Technique matters too. Using a new needle each time is important, as a blunted needle creates more tissue trauma. Pinching the skin gently, inserting at the right angle, and keeping the pen held in place until the injection is complete all reduce unnecessary irritation. If you are unsure about technique, the patient information leaflet that comes with your medicine is the authoritative reference, and our prescribers are available to help.
Most skin reactions with tirzepatide are local and self-limiting. A few patterns should prompt you to get help rather than wait.
A reaction that spreads well beyond the injection site, appears on skin you have not injected, or is accompanied by swelling of the lips, tongue, or throat could indicate a systemic allergic response. Difficulty breathing, a rapid or irregular heartbeat, or feeling faint alongside any skin change is a medical emergency. Call 999 or go to your nearest A&E. Do not drive yourself.
A reaction that does not improve within a week, gets progressively worse with each injection, or leaves a hard, painful lump that persists deserves a conversation with your prescriber. If you are trying to judge whether what you are experiencing counts as a bad reaction to Mounjaro, our page on that topic can help you weigh up the signs and decide how urgently to seek advice. Similarly, if the skin around the injection site becomes warm, weeping, or crusted in a way that suggests infection, seek advice promptly rather than continuing to inject into that area.
For anything that sits in the middle ground, our aftercare team is available seven days a week, and you can also use the MHRA's Yellow Card scheme to report reactions you think others should know about. Reporting is straightforward and does not require a healthcare professional to submit on your behalf.
If your reaction felt more severe or you want a broader picture of how reactions to tirzepatide have been characterised, our page on tirzepatide reactions generally covers that ground in more detail.
Get emergency help immediately if you have hives or widespread rash alongside throat tightening, swelling of the face, or breathing difficulty. These signs could indicate anaphylaxis, which is rare with tirzepatide but documented in its safety profile.
Contact your prescriber or GP the same day if: a local reaction has not improved after seven days; you develop a new skin change that you cannot explain; the area around the injection site looks infected; or the reaction is significantly worse than anything you experienced before. Our page on skin reactions to Mounjaro includes a helpful overview of what different reactions look like and when each one warrants escalation.
You do not need to tough out anything that worries you. Our clinical team reviews every repeat order before it is dispensed, and that check-in is a natural point to raise anything you have noticed since your last dose. People starting treatment, or those who have recently moved up a dose, sometimes find reactions ease once the new level becomes routine. That said, if you are uncertain whether what you experienced counts as a reaction to Mounjaro, our dedicated page covers the full range of presentations and can help you put your symptoms in context.
If you are considering tirzepatide and want to understand the full picture before you start, exploring what weight-loss treatment involves is a useful first step, and you can find more about how we approach safety on our about us page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.